• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Publications

Publications

Featured publications

Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow

July 28, 2025 | Journal of the American Society for Mass Spectrometry
Arnik Shah, et al.

Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow

Arnik Shah, Parth Shah, Alex Johnson, Jean Bender, Dmitry Gumerov, Jingwen Ding, Scott Mack, Matthew D. Stone, Maggie A. Ostrowski

>READ

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

November 2, 2023 | The New England Journal of Medicine
Mohit Mathur, et al.

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Mohit Mathur, Jonathan Barratt, Bobby Chacko, Tak Mao Chan, Laura Kooienga, Kook-Hwan Oh, Manisha Sahay, Yusuke Suzuki, Muh Geot Wong, Jill Yarbrough, Jing Xia, Brian J G Pereira

>READ

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

April 5, 2023 | Frontiers in Molecular Biosciences
Steven Pregizer, et al.

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

Steven Pregizer, Thom Vreven, Mohit Mathur, Luke Robinson

>READ

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.

October 30, 2009 | Science (New York, N.Y.)
Scott E Hensley et al.

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.

Scott E Hensley, Suman R Das, Adam L Bailey, Loren M Schmidt, Heather D Hickman, Akila Jayaraman, Karthik Viswanathan, Rahul Raman, Ram Sasisekharan, Jack R Bennink, Jonathan W Yewdell

>READ

Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions.

August 28, 2009 | Chemistry and Biology
Zachary Shriver et al.

Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions.

Zachary Shriver, Rahul Raman, Karthik Viswanathan, Ram Sasisekharan

>READ

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

July 5, 2009 | Science (New York, N.Y.)
Taronna R Maines et al.

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

Taronna R Maines, Akila Jayaraman, Jessica A Belser, Debra A Wadford, Claudia Pappas, Hui Zeng, Kortney M Gustin, Melissa B Pearce, Karthik Viswanathan, Zachary H Shriver, Rahul Raman, Nancy J Cox, Ram Sasisekharan, Jacqueline M Katz, Terrence M Tumpey

>READ

Extrapolating from sequence–the 2009 H1N1 ‘swine’ influenza virus.

June 1, 2009 | Nature Biotechnology
Venkataramanan Soundararajan et al.

Extrapolating from sequence–the 2009 H1N1 ‘swine’ influenza virus.

Venkataramanan Soundararajan, Kannan Tharakaraman, Rahul Raman, S Raguram, Zachary Shriver, V Sasisekharan, Ram Sasisekharan

>READ

Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses.

February 19, 2008 | Proceedings of the National Academy of Sciences of the United States of America
Aravind Srinivasan et al.

Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses.

Aravind Srinivasan, Karthik Viswanathan, Rahul Raman, Aarthi Chandrasekaran, S Raguram, Terrence M Tumpey, V Sasisekharan, Ram Sasisekharan

>READ

Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin.

January 6, 2008 | Nature Biotechnology
Aarthi Chandrasekaran et al.

Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin.

Aarthi Chandrasekaran, Aravind Srinivasan, Rahul Raman, Karthik Viswanathan, S Raguram, Terrence M Tumpey, V Sasisekharan, Ram Sasisekharan

>READ
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6

© 2025 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design

We use cookies on our website to see how you interact with it. By accepting, you agree to our use of such cookies. Privacy PolicyOk